PSA unveils Health Destination Pharmacy program


pharmacists sitting at a computer

PSA’s Health Destination Pharmacy program, a coaching and development program to help pharmacies deliver financially viable health services, was officially unveiled at PSA15.

PSA’s HDP program is evidence-based with proven results, says PSA, is backed by industry leaders, and is delivered by Australia’s most experienced experts in pharmacy change.

National President of the PSA, Joe Demarte, says the program is a financially viable and sustainable change platform for pharmacies.

“Importantly, it is a key strategy of the PSA vision for excellence in pharmacist care,” Demarte says.

He says the HDP program assists pharmacies to transition from reliance on a price-focused, discount model to a consumer-focused model – one that is adaptive to local community needs and demographics.

“It is a program that is evidence based, allowing pharmacies to experience high levels of patient loyalty, pharmacists’ satisfaction, and financial sustainability less reliant on government funding,” he says.

“HDP acknowledges that change is sometimes difficult, and our program uses a change model that is tried and tested to support pharmacies through the transition to a consumer-focused and financially sustainable practice.

“The program uses an intense coaching model underpinned by evidence, targeting strategies in areas such as business and financial planning, people and processes, marketing, layout, and infrastructure.

“PSA is in a unique position to deliver this coaching expertise and network, whilst working with experts in implementation, business processes and financial management.

“HDP is the complete solution for pharmacies to support health-focussed changes to their pharmacies. It provides the foundation for professional and financial success.

“It is informed, endorsed, and supported by the leading experts in pharmacy business practices. It brings together the best of the best,” Demarte says.

To progress the implementation phase, PSA says it has teamed-up with those organisations with a shared interest in excellence in pharmacists’ care and wish to see a more viable community pharmacy sector.

This partnership is unprecedented and reflects the confidence the industry has in the project and its outcomes, it says.

The partners are Pfizer Australia, Bayer, Reckitt Benckiser (RB), Johnson & Johnson, Blackmores, Willach Australia, NAB Health and Danone Nutricia.

Representatives of these companies are members of the advisory group that also includes experts Professor Charlie Benrimoj from the University of Technology Sydney, Bruce Annabel from JR Pharmacy Services and Glenn Guilfoyle from The Next Level.

Previous Shanae Hancey is 2015 Pharmacy Student of the Year
Next Guidelines to standardise sleep apnoea services

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.